REQUEST A DEMO
Total
USD $0.00
Search more companies

GeneCode AS (Estonia)

Main Activities: Research and Development in Nanotechnology | Research and Development in Biotechnology (except Nanobiotechnology)
Full name: GeneCode AS Profile Updated: November 12, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Russian Download a sample report

GeneCode AS is based in Estonia, with the head office in Tallinn. It operates in the Research and Development in Nanotechnology industry. It was first established on January 15, 1998. 3 (2023) employees currently work for GeneCode AS. There was a total growth of 40.01% in GeneCode AS’s total assets over the same period.

Headquarters
Ahtri tn 8 Kesklinna linnaosa
Tallinn; Harju county; Postal Code: 10151

Contact Details: Purchase the GeneCode AS report to view the information.

Basic Information
Total Employees:
Purchase the GeneCode AS report to view the information.
Registered Capital:
Purchase the GeneCode AS report to view the information.
Financial Auditors:
Purchase the GeneCode AS report to view the information.
Incorporation Date:
January 15, 1998
Key Executives
Purchase this report to view the information.
Member of the Supervisory Board
Purchase this report to view the information.
Member of the Supervisory Board
Purchase this report to view the information.
Member of the Supervisory Board
Purchase this report to view the information.
Member of the Supervisory Board
Purchase this report to view the information.
Member of Management Board
Company Performance
Financial values in the chart are available after GeneCode AS report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Operating profit (EBIT)
-21.47%
EBITDA
-21.34%
Net Profit (Loss) for the Period
-24.67%
Total assets
40.01%
Total equity
24.62%
Return on Equity (ROE)
-12.93%
Cash Ratio
0.06%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?